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Introduction
Breast cancer affects one in 10 women in Western coun-
tries. Current theories suggest cancer is a disease of stem
cells [1], and it is therefore important to identify breast
epithelial stem cells as potential targets both for therapeu-
tic intervention and for breast cancer prevention. Trans-
plantation studies in the mouse have shown that stem
cells are present throughout mammary ductal and lobular
structures, and may be particularly enriched in end buds,
the rapidly growing tips of the emerging ductal network
[2]. Analysis of mouse mammary tumour virus (MMTV)
retroviral integration sites has shown that a complete
mammary gland can develop from the progeny of a single
cell, but the identity of this cell is unclear [3]. Undifferenti-
ated cap cells at the tips of the end buds have been sug-
gested to be stem cells, largely based on their location
[2]. Morphological studies have also suggested that undif-
ferentiated small light cells distributed within mammary
ducts may be stem cells [4]. Functional data confirming
these assignments have been missing due to the lack of
appropriate cellular markers that can be used to isolate
live cells. Two main developmental motifs (ductal and
lobular) and two main cell types (myoepithelial and
luminal) are found within the mammary gland. However,
BCRP = breast cancer resistance protein; bp = base pairs; DMEM = Dulbecco’s modified Eagle’s medium; FACS = fluorescence-activated cell
sorter; FCS = foetal calf serum; H & E, haemotoxylin and eosin; MMTV = mouse mammary tumour virus; PBS = phosphate-buffered saline; RT-PCR
= reverse transcriptase-polymerase chain reaction; SP = side population; TERT = telomerase catalytic subunit.
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Abstract
Background: Breast cancer is thought to arise in mammary
epithelial stem cells. However, the identity of these stem cells
is unknown.
Methods: Studies in the haematopoetic and muscle systems
show that stem cells have the ability to efflux the dye Hoechst
33342. Cells with this phenotype are referred to as the side
population (SP). We have adapted the techniques from the
haematopoetic and muscle systems to look for a mammary
epithelial SP.
Results:  Of mammary epithelial cells isolated from both the
human and mouse mammary epithelia, 0.2–0.45% formed a
distinct SP. The SP was relatively undifferentiated but grew as
typical differentiated epithelial clones when cultured.
Transplantation of murine SP cells at limiting dilution into
cleared mammary fat pads generated epithelial ductal and
lobuloalveolar structures.
Conclusion: These data demonstrate the existence of an
undifferentiated SP in human and murine mammary epithelium.
Purified SP cells are a live single-cell population that retain the
ability to differentiate in vitro and  in vivo. Studies of
haematopoetic cells have suggested that the SP phenotype
constitutes a universal stem cell marker. This work therefore
has implications for mammary stem cell biology.
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the relationship between stem cells and these cell popula-
tions remains unclear.
Flow cytometric analysis of haematopoetic and muscle
cells has shown that Hoechst dye exclusion defines a side
population (SP) of stem cells for both tissues [5,6]. It has
been postulated that the SP is a universal stem cell phe-
notype [6]. We have now identified human and mouse
breast epithelial SP cells and have shown that they consti-
tute an undifferentiated subpopulation that can differenti-
ate into ductal and lobular structures and into
myoepithelial and luminal epithelial cell types.
Materials and methods
Isolation of human epithelial cells
Breast tissue derived from reduction mammoplasties was
cut up manually into small pieces (approximately 0.5 cm
cubed) and digested overnight at 37°C in a shaking incu-
bator with 0.5–1 mg/ml collagenase (Type I; Sigma,
Poole, UK) in phenol-red free DMEM (Gibco, Paisley, UK)
supplemented with 5% charcoal-treated serum. Following
enzyme digestion, the fat layer was decanted and the
epithelial pellet was washed several times with DMEM
medium. The breast organoids (ductal and lobuloalveolar
structures) were isolated from red blood cells, fibroblasts
and endothelial cells by sequential filtration and backflush-
ing from 140 and 53 µm pore size polyester monofilament
meshes (Locker Tex, Warrington, UK) as described by
Hallowes et al. [7]. The pooled organoids were disaggre-
gated by pipetting in 0.25% trypsin-EDTA (Sigma), fol-
lowed by filtration through a 40 µm mesh (Becton
Dickinson, San Jose, CA, USA) to yield a predominantly
single-cell suspension.
Isolation of mouse mammary epithelial cells
Primary mouse mammary epithelial cells were harvested
essentially as described by Smalley et al. [8], with modifi-
cations described by Naylor et al. [9]. In brief, the fourth
mammary fat pads were removed from 8-week-old to 10-
week-old virgin female FVB mice and were subjected to
mechanical and enzymatic digestion to obtain epithelial
‘organoids’. Contaminating fibroblasts were removed by
differential plating and the organoids were enzymatically
digested to single cells. Primary cells were then directly
processed for Hoechst staining without intervening
culture.
Isolation of mouse bone marrow cells
Femurs from FVB mice were dissected out. The ends of
each bone were snipped off with dissecting scissors, and
a 5 ml syringe containing PBS and equipped with a 25 G
needle (Terumo, Leuven, Belgium) was used to flush out
the bone marrow from both ends of the bone. The result-
ing diluted bone marrow was washed with L15/10% FCS
and pelleted. Red cells were lysed by resuspending the
pellet in 1 ml red blood cell lysing buffer (Sigma), pipetting
up and down briefly, and incubating for 5 min at 37°C. If
red cells were still present after washing (red colour in the
pellet), the lysis procedure was repeated once more.
Clonal culture of primary mouse mammary epithelial
cells
For analysis of the morphology and the cloning efficiency,
mouse mammary epithelial cells were plated at 2000 cells
per flask in 25 cm2 tissue culture flasks containing 5 × 105
irradiated (20 Gy) 3T3-L1 mouse fibroblast (ATCC,
Bethesda, MD, USA) feeders. Cultures were maintained in
a 1:1 mix of DMEM and Ham’s F12 (Gibco) supplemented
with 10% FCS, 5 µg/ml insulin, 10 ng/ml cholera toxin
(Sigma) and 10 ng/ml epidermal growth factor (Sigma).
Cultures were kept in a 90% nitrogen/5% carbon
dioxide/5% oxygen environment for optimal clonal growth
as previously described [8]. After 8 days in culture, flasks
were fixed in 0.5% glutaraldehyde in PBS, clones were
photographed and the flasks were then stained with
haematoxylin to allow counting of colony numbers. To
assess levels of contaminating fibroblasts in the cell
preparations, cells were plated at clonal density in 25 cm2
flasks with 10T1/2 (ATCC) feeders that expressed β-
galactosidase (to distinguish them from any contaminating
fibroblasts), or at 4 × 104 per 25 cm2 flask without feeders,
in DMEM/10% FCS, and maintained in 5% CO2/air only.
To assess levels of contaminating haematopoetic cells,
mouse mammary SP cells were cultured under conditions
previously established for the culture of bone marrow-
derived cells [10].
Antibodies and reagents
All reagents came from Sigma unless otherwise stated.
Antibodies LL002 (anticytokeratin 14), LE61 (anticytoker-
atin 18) and LP2K (anticytokeratin 19) were kind gifts from
EB Lane. Antibodies 33A10 (anti-epithelial membrane
antigen) and GoH3 (anti-α6 integrin) were kind gifts from
A Sonnenberg. Antivimentin V9 and anti-α-isoform smooth
muscle actin 1A4 were purchased from Sigma. Anti-CD45
antibody I3/2.3 and fluorochrome-conjugated secondary
antibodies were purchased from Cambridge Bioscience
(Cambridge, UK). The antitelomerase catalytic subunit
antibody was purchased from Calbiochem (Nottingham,
UK). The anti-oestrogen receptor antibody was purchased
from DAKO (Ely, UK).
Hoechst 33342 staining of cells
Mouse bone marrow and epithelial cells were resus-
pended at 106/ml in L15/10% FCS prewarmed to 37°C
(DMEM/10% FCS for human breast epithelial cells), and
Hoechst 33342 (Molecular Probes, Leiden, The Nether-
lands) was added at a final concentration of 5 µg/ml. Vera-
pamil (Fluka; Sigma) was added to samples at a final
concentration of 20 µM, and was more toxic to mouse
mammary SP cells than to bone marrow cells or human
mammary SP cells (data not shown). Cells were incubatedR3
for 90 min at 37°C with occasional agitation. After incuba-
tion, cells were washed with cold medium and resus-
pended at (2–3) × 106/ml, and propidium iodide
(Molecular Probes) was added to a final concentration of
2 µg/ml.
Flow cytometry
Cells were sorted on a BD FACSVantageSE cell sorter
(Becton Dickinson) either into tubes, onto poly-L-lysine-
coated slides (BDH; Merck Ltd, Lutterworth, UK), or into
culture plates using the CloneCyto system. The machine
is equipped with two Coherent 90 C-4 argon ion lasers
(Coherent, Santa Clara, CA, USA), one with visible optics
set to 488 nm and one with multiline UV optics
(333.6–333.8 nm). Hoechst 33342 fluorescence was
measured at both 424/44 nm and above 670 nm (split by
a 610 nm short-pass dichroic mirror), both from UV excita-
tion. Dead cells were excluded by propidium iodide fluo-
rescence measured at 564–606 nm.
Immunofluorescence analysis
Cells were plated at a density of 500/well on glass cover-
slips set up in 24-well plates with 2000 irradiated feeders
per well, using the same growth conditions as already
described. After 8 days, coverslips were fixed in ice-cold
50:50 methanol:acetone for 5 min, and then stained.
Alternatively, cells were sorted directly onto poly-L-lysine-
coated slides, and then air-dried and fixed as already
described. Cells were stained by multiple indirect immuno-
fluorescence as described elsewhere [8] using mouse
and rat primary monoclonal antibodies against the anti-
gens presented in Table 1, and species, class and sub-
class-specific secondary antibodies conjugated to
fluorescein isothiocyanate or Texas Red (Cambridge Bio-
science). No first antibody controls were used to screen
for nonspecific binding of secondary antibodies. Addi-
tional controls involved showing that several primary anti-
bodies were negative for staining to mouse mammary SP
cells. These included anti-Ep-CAM (Ab4 Clone ESA 43;
IgG1), anti-CD34 (RAM34; IgG2aK), anti-c-Kit (CD117,
clone 2b; IgG2bK) and FLK1 (IgG2a). Stained cultures
were observed using a Zeiss Axiovert inverted microscope
(Carl Zeiss Ltd, Welwyn Garden City, UK) and were pho-
tographed. Cell counts taken from the photographs were
used to determine the percentage of brightly stained cells.
Cleared fat-pad transplantation
Transplantation into epithelial-free fourth mammary fat
pads of 21-day-old FVB mice was carried out as
described previously [9,11,12]. Freshly harvested SP and
non-SP cells were transplanted at varying numbers as
already described. Transplants were given 8 weeks to
grow before either being harvested or allowing host
animals to be mated. Transplanted fat pads from mated
animals were harvested on days 17–18 of pregnancy.
Harvested glands were fixed and carmine-stained as
whole mounts. After being photographed, pieces of inter-
est were dissected out of the whole mounts, embedded in
paraffin blocks and processed by standard histological
techniques for H & E sections and immunocytochemistry.
RT-PCR analysis of ABC transporter proteins
For RT-PCR analysis of multidrug-resistant protein expres-
sion in mammary epithelial cells, RNA was isolated using
Rneasy spin columns (QIAGEN Ltd, Crawley, UK). RT
reactions were carried out on RNA from approximately
1000 cells using Sensiscript RT (QIAGEN) and an oligo
dT primer according to the manufacturer’s instructions.
Control reactions with no enzyme were carried out in par-
allel. PCR amplification was carried out on one-fifth of the
RT or control reactions. The expression of four ABC
transporter proteins (breast cancer resistance protein 1,
multidrug resistance-associated protein 1, multidrug resis-
tance-associated protein 3 and multidrug resistance-
associated protein 4) was analysed; primer sequences for
these were kindly provided by Brian Sorrentino [6].
Results
Identification of human and murine SP cells
Epithelial cells isolated from nine independent, normal
human breast samples were stained with Hoechst and
analysed by FACS. Each preparation contained a small
fraction of cells (0.18 ± 0.23%) that exhibited a SP
(Fig. 1a). The formation of the SP population was blocked
by 20 µM verapamil, consistent with previous studies
showing a requirement for ABC transporter family function
in the SP phenotype (Fig. 1b) [5]. The SP was found in all
samples regardless of age, parity, contraceptive status or
day of menstrual cycle (Table 1).
Available online http://breast-cancer-research.com/content/5/1/R1
Table 1
Side population (SP) proportion and hormonal status
Day of 
Age Term  menstrual 
(years) SP (%) pregnancy Contraception cycle
33 0.03 None COC 8/28
43 0.68 – – –
39 0.47 4 (breast fed) None 21/28
40 0.07 None None 15/28
19 0.14 None COC 14/28
22 0.15 None DeproProvera N/A
39 0.07 1 (breast fed) None 20/–*
43 0.01 2 (breast fed) None 14/28
57 0.03 2 (breast fed) None 8/21
Relating percentage of SP found in nine different patients with age,
number of pregnancies, use and type of contraceptives and day of
menstrual cycle. COC, combined oral contraceptive. * Irregular cycle
length.We next examined whether the SP was present in mouse
mammary epithelial cells. Results from 17 independent
experiments showed that 0.45 ± 0.22% of mouse
mammary epithelial cells had the SP phenotype (Fig. 2a).
This proportion of cells exhibiting the mammary SP pheno-
type was similar to that observed in similarly stained
mouse bone marrow samples (0.14 ± 0.11%) (Fig. 2b)
and was in line with previous studies [5]. Representative
flow cytometry traces of Hoechst-stained cells from
mouse mammary epithelium and mouse bone marrow are
shown in Figure 2a,b. The increased availability of SP cells
from the mouse mammary epithelium encouraged us to
move to a mouse model for subsequent studies.
Markers of SP mammary epithelial cells
The SP phenotype is thought to arise through the action
of ABC transporter cassette proteins, and in particular
ABCG2/breast cancer resistance protein 1 [6]. RT-PCR
analysis of mouse mammary SP cells confirmed the
expression of breast cancer resistance protein 1, as well
as three other members of the ABC transporter family
(multidrug resistance-associated protein 1, multidrug
resistance-associated protein 3 and multidrug resistance-
associated protein 4) at lower levels (Fig. 2c).
To immunophenotype mouse mammary epithelial SP and
non-SP cells, they were directly sorted on to poly-L-lysine-
coated slides and stained by indirect immunofluorescence
(Table 2). The results suggest that SP cells are a relatively
undifferentiated population that express lower levels of
cytokeratins and higher levels of vimentin than non-SP
cells. Vimentin expression is not exclusive to fibroblasts
and has previously been described in mammary epithelial
cells [13]. Levels of CD45-expressing cells were low in the
SP fraction while CD34 and Flk1 were not expressed, sug-
gesting that mammary SP cells were not significantly cont-
aminated with blood stem cells. Similar proportions of cells
expressed the oestrogen receptor in both SP and non-SP
cells. Interestingly, the SP fraction was enriched for cells
that express the catalytic subunit of telomerase [14]. The
results from these studies, while not yet statistically signifi-
cant, have important mechanistic implications for the origin
of oestrogen receptor-positive and oestrogen receptor-
negative tumours, and require further investigation.
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Figure 1
Flow-cytometric analysis of human breast epithelial cells stained with
5 µM Hoechst 33342. (a) Trace demonstrating the presence of a side
population (box). (b) Addition of 20 µM verapamil (+v), resulting in a
12-fold reduction in the side population. X axis, Hoechst red
fluorescence intensity (FL5); Y axis, Hoechst blue fluorescence
intensity (FL4).
Figure 2
Analysis of mouse side population (SP) cells. Flow cytometric analysis of mouse cells stained with Hoechst 33342: (a) SP in mouse mammary
epithelial cells (box), (b) SP in mouse bone marrow cells. X axis, Hoechst red fluorescence intensity (FL5); Y axis, Hoechst blue fluorescence
intensity (FL4). (c) RT-PCR analysis of ABC transporter cassette proteins in SP and non-SP cells from mouse mammary epithelial cells. M,
molecular weight marker; Brcp1, breast cancer resistance protein; Mrp, multidrug resistance-associated protein. Sizes of bands: Brcp1, 327 bp;
Mrp1, 701 bp; Mrp3, 301 bp; Mrp4, 222 bp.In vitro and in vivo differentiation of SP cells
To characterise the in vitro differentiative potential of the
mammary SP, cells were plated under conditions
designed to promote the growth of mammary epithelial
cells, haematopoetic colonies or fibroblasts. Haematopo-
etic culture conditions supported growth of bone marrow-
derived SP cells, but they did not support the growth of
mammary-derived SP cells (data not shown). Similarly,
fibroblast culture conditions supported the growth of
primary mouse fibroblasts, but there was no growth of
fibroblast-type cells under such conditions in cultures in
which either SP or non-SP cells had been plated, either at
clonal density or in bulk culture (data not shown). It thus
seems unlikely that contaminating haematopoetic cells or
fibroblasts make up the bulk of the SP fraction seen in
mouse mammary epithelial cell preparations. By contrast,
culture of both SP and non-SP cells under conditions pre-
viously optimised for mouse mammary clonal culture
resulted in the growth of mouse epithelial clones [8], with
mean cloning efficiencies of 4.7 ± 0.55 and 2.1 ± 1.6%,
respectively (2000 cells plated per flask; n = 5).
The morphology and ratios of the clone types were consis-
tent with the type A–D classification found when unsorted
primary mammary epithelial cells were cloned [8,15]. Iden-
tical clone types and ratios of types A–D were observed
following growth of SP and non-SP preparations.
Double immunofluorescence staining of clones, using the
antibodies LE61 and LP2K (anticytokeratin 18 and anti-
cytokeratin 19, respectively; in vivo markers of mammary
luminal epithelial cells) and LLOO2 (anticytokeratin 14; a
marker of mammary myoepithelial cells) [8,15], demon-
strated that SP-derived and non-SP-derived clones had
identical staining patterns. All were uniformly strongly posi-
tive for cytokeratin 18, and most cells within clones also
double stained for cytokeratin 14. Staining for cytokeratin
19 was more heterogeneous. Occasional cells, apparently
lying below the clonal ‘monolayer’, were cytokeratin
14-positive only (data not shown). Such promiscuous pat-
terns of cytokeratin expression in mammary epithelial-
derived clones are fully consistent with our previous data
and suggest that SP cells differentiate into classic
mammary epithelial cell clones following in vitro culture.
To examine their in vivo differentiative potential, SP cells that
had been freshly isolated and had not undergone any inter-
vening culture period were transplanted at <5 × 103 cells
per fat pad into mammary fat pads of syngeneic animals from
which the endogenous epithelium had been removed
(‘cleared’) [11]. Transplants were given 5–8 weeks to
develop and then animals were mated. Transplanted glands
were harvested on days 17–18 of pregnancy.
Outgrowths were observed in five of 37 SP transplanted
fat pads. These outgrowths consisted of four lobuloalveo-
lar structures and one ductal–lobular outgrowth (ducts
and lobules) according to the classification of mammary
transplant outgrowth types of Kordon and Smith [3]. Six
out of 25 non-SP transplanted fat pads contained out-
growths, although comparisons between SP and non-SP
transplant rates may be unwarranted (see Discussion).
H & E staining of sections through the SP outgrowth lobu-
loalveolar structures (Fig. 3a–h) showed that they con-
sisted of a number of tightly packed alveoli with central
lumina surrounded by layers of luminal epithelial and
myoepithelial cells. Staining for markers of myoepithelial
and luminal epithelial cells (α-smooth muscle actin and
cytokeratin 19) confirmed the identity of myoepithelial and
luminal epithelial cells, respectively [8,15].
Discussion
We have demonstrated the presence of SP cells within
the human and mouse mammary glands. SP cells were
undifferentiated, and they generated ductal and lobular
structures containing both myoepithelial and luminal
epithelial cell types upon transplant in vivo. Mammary SP
cells were detected in all human breast samples studied,
although no correlation was detected between age, parity,
contraceptive status or day of menstrual cycle. It is possi-
ble that subtle changes in SP frequency were masked by
the experimental variables inherent in preparing primary
breast material for FACS analysis. The inhibition of the SP
phenotype by verapamil together with the expression of
breast cancer resistance protein (BCRP) suggest that the
BCRP-dependent transporter function could be a major
contributor to the ability of mammary SP cells to export
Hoechst dye [6]. Recent studies suggest that BCRP
expression in the normal human breast is heterogeneous
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Table 2
Antibody staining profiles
Cytokeratin Cytokeratin  Epithelial  membrane  Oestrogen 
14 19  antigen  receptor  Telomerase 
(clone LL002) (clone LP2K) Vimentin (clone 33A10) α6-Integrin (clone 1D5) CD45 (clone α-TERT)
SP 0.5 (567) 5 (309) 63 (194) 4 (356) 44 (396) 41 (108) 5 (290) 35 (99)
Non-SP 15 (265) 39 (144) 23 (100) 16 (102) 10 (181) 56 (113) 40 (211) 5 (86)
Data presented as the percentage of bright cells (number of cells counted). Summary of staining profiles for mouse mammary epithelial side
population (SP) and non-SP cells.[16]. However, further work will be required to determine
whether BCRP expression can be used as a molecular
marker for SP/stem cells. With the development of appro-
priate reagents, the relationship between SP/stem cell
phenotype and breast cancer risk could be explored.
Freshly isolated SP cells expressed low levels of differenti-
ated markers for both luminal (epithelial membrane antigen
and cytokeratin 19) and myoepithelial cell types (cytoker-
atin 14). Oestrogen receptor expression was detected in
SP cells, suggesting that these cells have the capacity to
respond to the proliferative effects of oestrogen. Signifi-
cantly, expression of the telomerase catalytic subunit was
higher in SP compared with non-SP cells. The telomerase
catalytic subunit mRNA is expressed within mitotically
inactive regions of breast terminal ducts and lobules, and
is associated with stem cell compartments in other tissues
[17]. An increase in telomerase activity is one of the earli-
est events in breast tumourigenesis and has been shown
to drive cellular immortalisation [17,18].
While the present article was under review, Welm and col-
leagues published a report showing that Sca-1-positive
cells were enriched for stem cell precursors and that
mouse mammary SP cells expressed high levels of Sca-1
[19]. Our data confirm their observation that SP cells are
present in the mouse mammary gland, and we have
subsequently shown that Sca-1 is differentially expressed
in SP versus non-SP cell preparations (15.8% SP:1.8%
non-SP in cells from FVB mice). These percentages were
comparable with those observed in the B6/129 mice char-
acterised by Welm et al. [19]. Unlike Welm et al.,
however, we directly recovered sufficient live SP cells to
allow an analysis of primary SP cell transplantation poten-
tial and in vitro growth potential.
Following in vitro culture, murine SP cells express classic
mammary epithelial markers including cytokeratin 14,
cytokeratin 18 and cytokeratin 19, suggesting that culture
conditions promote differentiation. Previous studies have
shown that unsorted epithelial cells grown under these
conditions retain the ability to repopulate the mammary
gland upon transplantation [20]. However, the identity of
the clonal type(s) that retain in vivo stem cell potential
remains unclear. When unsorted primary epithelial cells
were cultured in bulk for 8 days prior to Hoechst staining,
the classic SP FACS profile was not observed (data not
shown). The loss of the SP phenotype may be due to a
reduction in the proportion of SP cells following culture.
Alternatively, the ability of cells to exclude Hoechst dye
may be increased by in vitro culture such that the SP frac-
tion can no longer be distinguished. Considerable cellular
heterogeneity exists within three of the four previously
described epithelial clone types (types A–D) [8,15], and it
is probable that only some cells within the colonies retain
the ability to repopulate the mammary gland.
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Figure 3
Histology and immunocytochemistry of two representative side
population (SP) outgrowths. (a), (b) Wholemount morphology of
carmine-stained outgrowths from transplanted mouse mammary side
population cells. Lobuloalveolar structures indicated by dashed
outlines. Bar = 750 µm. (c), (d) H & E-stained section of SP
outgrowth. (e), (f) Immunocytochemical staining of the section of SP
outgrowth for the myoepithelial cell marker α-smooth muscle actin. 
(g), (h) Immunohistochemical staining of the section of SP outgrowth for
the luminal epithelial cell marker cytokeratin 19. (c)–(h) Bar = 350 µm.Transplantation of SP cells at limiting dilution generated
lobuloalveolar and ductal–lobular structures at low fre-
quency, which is an encouraging finding given that as few
as 2000 cells were used. Non-SP cells also generated out-
growths. In the current study, the relative rates of SP trans-
plantation versus non-SP transplantation should not be
directly compared because very low numbers of SP cells
were generated in each primary cell preparation and
because comparisons between batches of primary cells
were hampered by the toxic effects of Hoechst staining
(data not shown). The morphology of the ductal–lobular
and lobuloalveolar structures derived from SP cells resem-
bled that previously described for mammary epithelial clone
types in vivo [3]. The lobular structures had a histology that
was consistent with the late stage of pregnancy from which
they were isolated, and both myoepithelial and luminal cells
were expressed in the appropriate cellular layers. These
data together suggest that mammary SP cells retain a full
differentiative and developmental potential.
If SP cells were pure mammary stem cells, it might be
expected that they would be highly enriched for the ability
to repopulate the fat pad following transplantation, as has
been shown for Sca-1-enriched cells [19]. However, a
direct comparison with Sca-1 enrichment studies may not
be valid. One of the assumptions underlying mammary
transplant studies is that mammary outgrowths at limiting
dilution are clonal (14,000–20,000 cells per cleared fat
pad) [21] Recent data show that this assumption may be
incorrect. When a population of epithelial cells containing
10% lacZ-positive marked cells was transplanted at limit-
ing dilution, all transplant outgrowths were found to
contain mixtures of lacZ-positive and lacZ-negative cells
[22]. As the rate of transplants ‘takes’ in these experi-
ments was normal, this suggests that more than one cell
may be required for a successful transplant [22]. In this
context, the study of Sca-1-enriched cells [19] may not be
comparable with that of SP cells, because SP cells com-
prise 0.2–0.45% of epithelial cells while Sca-1 cells are
100 times more common, comprising 20% of the total
mammary epithelial population. Thus, 99.7% of non-SP
cells may contain additional (Sca-1-positive) cells that
enhance the rate of transplantation [21] or directly con-
tribute to a polyclonal outgrowth. A key study showing
polyclonal MMTV-infected glands become monoclonal
with respect to the site of MMTV integration following
serial transplantation [3] provided evidence for the pres-
ence of single totipotent mammary stem cells, but did not
show that the single cell was able to generate complete
outgrowths at limiting dilution.
In the longer term, approaches to identify surface markers
and strategies for isolating healthy SP-like cells need to
be developed to allow the clear identification of putative
stem cells. In addition, a better understanding of the
clonal composition of outgrowths should allow the use of
mammary transplantation as a quantitative assay for stem
cell enrichment.
Conclusion
We have identified human and mouse SP cells. We show
that mammary SP cells are an undifferentiated subfraction
of total epithelial cell preparations. SP cells retain the
potential to differentiate into typical mammary clones in
vitro and into normal lobular and ductal structures in vivo.
As haematopoetic SP cells are enriched for stem cell pre-
cursors, the present data is of direct relevance to the iden-
tity of mammary stem cells.
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